Amycretin achieves 13% weight loss within three months with once-a-day tabletIndividuals who received a once-a-day oral weight loss drug, Amycretin developed by Novo Nordisk, lost up to 13% of their body weight...
Key factors that can impact long-term weight loss in patients with obesity prescribed GLP-1 RA medications6 days ago